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A B S T R A C T
Laser capture microdissection (LCM) allows microscopic procurement of speciﬁc cell types from tissue
sections. Here, we present an optimized workﬂow for coupling LCM to LC–MS/MS including: sectioning
of tissue, a standard LCM workﬂow, protein digestion and advanced LC–MS/MS. Soluble proteins
extracted from benign epithelial cells, their associated stroma, tumor epithelial cells and their associated
stromal cells from a single patient tissue sample were digested and proﬁled using advanced LC–MS/MS.
The correlation between technical replicates was R2 = 0.99 with a mean % CV of 9.55%  8.73. The
correlation between sample replicates was R2 = 0.97 with a mean % CV of 13.83%  10.17. This represents a
robust, systematic approach for proﬁling of the tumor microenvironment using LCM coupled to label-free
LC–MS/MS.
ã 2015 The Authors. Published by Elsevier B.V. on behalf of European Proteomics Association (EuPA). This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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A workﬂow using laser capture microdissection (LCM) that
would allow for both targeted and unbiased proteomic proﬁling of
speciﬁc target cells in tissue (that may also include, for example,
immuno-MRM) could be invaluable to several experimental and
clinical ﬁelds. Since its establishment, LCM has predominantly
been coupled with genomic and transcriptomic analysis for large-
scale studies, whereas proteomic analysis has largely lagged
behind in this area due to the limited amount of sample routinely
acquired using LCM. Today, while some may still argue that LCM is
too challenging and labor intensive for the resulting low protein
yields, the sensitivity of mass spectrometers has increased
exponentially in the last number of years allowing analysis of
scarce protein samples and even single cell analysis [1] as well as
global proteome mapping [2]. Therefore it is now reasonable toAbbreviations: LCM, Laser capture microdissection; LC–MS/MS, Liquid chroma-
tography tandem mass spectrometry.
* Corresponing author at: UCD Conway Institute of Biomolecular and Biomedical
Research, School of Medicine and Medical Science, University College Dublin,
Belﬁeld, Dublin 4, Ireland.
E-mail address: stephen.pennington@ucd.ie (S.R. Pennington).
http://dx.doi.org/10.1016/j.euprot.2015.11.001
2212-9685/ã 2015 The Authors. Published by Elsevier B.V. on behalf of European Proteom
(http://creativecommons.org/licenses/by-nc-nd/4.0/).perform large-scale LCM using limited sample amounts for global
proteome analysis to complement those that are routinely
performed using genomics and transcriptomic technologies.
Several laboratories have studied differential protein expression
in microdissected tumor tissue specimens in an effort to discover
novel tumor markers [3–5]. However, the semi-quantitative
approaches used in these studies may have limited the number
of potential markers identiﬁed as well as the reliability of protein
quantiﬁcation. In order to minimize technical variations and
improve reliability of protein quantiﬁcation, a variety of sophisti-
cated stable isotope labeling techniques have been developed for
MS-based proteomics including chemical, metabolic, and enzy-
matic labeling techniques. Isotope-coded afﬁnity tags (ICAT),
isobaric tags for relative and absolute quantiﬁcation (iTRAQ) and
O18 labeling coupled with mass spectrometry provide a means of
post-harvest protein labeling for protein quantiﬁcation whereby
relative protein expression levels are determined by the ratio of the
ion intensities of the isotopically labeled peptide pairs and have
successfully been applied to LCM material [6–10]. However, such
labeling strategies require a relatively large amount of sample
(100 mg), which requires enormous amounts of sectioned tissue for
LCM not to mention the vast amount of LCM time. In addition such
strategies require extensive sample handling and manipulationics Association (EuPA). This is an open access article under the CC BY-NC-ND license
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label-free approaches in particular where peptide abundance
information is critical for comparative proteome analysis, it is
imperative that sample handling and manipulation be kept to a
minimum. Moreover, while these efforts demonstrate signiﬁcant
promise, their scale is modest and undertaking larger scale analysis
of individual patient tissue samples remains a formidable
challenge [11].
This paper describes a robust systematic approach to coupling
LCM with advanced LC–MS/MS using a telepathology approach for
the proteomic proﬁling of the tumor microenvironment (Fig. 1).
LCM requires accurate identiﬁcation of the cells to be targeted and
hence the pathologist has a central role in LCM-based experiments.
As such, the limiting factor in LCM is generally the availability of an
expert pathologist to guide the tissue micro-dissection. The
telepathology approach ensures that pathological evaluation is
central to the identiﬁcation and annotation of the correct target
cells for downstream proteomic analysis as well as recording any
morphological changes as sequential sections are cut through the
tissue (Fig. 1). The use of short-range separation allows for the
concentration of low protein quantities into a single gel plug for
digestion, helps minimize protein loss by minimal sample
handling and manipulation and facilitates the removal of SDS
for subsequent MS analysis.
In order to establish the effects of protein concentration for
sufﬁcient protein identiﬁcations, increasing protein yields were
concentrated using short range SDS-PAGE gel electrophoresis and
subjected to LC–MS/MS. Fig. 2 shows the separation of 0.5 mg-
15 mg of crude prostate tissue protein lysate separated based on
molecular weight using a 6% SDS-PAGE gel (Fig. 2A) followed byFig. 1. Systematic workﬂow for the coupling of LCM to advanced LC–MS. Fig.1(A) show
pathology review, using annotated images for correct cellular accrual to proteomic p
telapathology approach implemented as part of the optimized workﬂow. Fig. 1(C) shows 
section taken at the Dana Faber and posted to UCD. Panel B shows the sixth H&E cut se
sections, respectively. Fig. 1(D) depicts the LCM of tumor epithelium and associated strom
before LCM is shown in D(ii), tumor epithelial cells after LCM are shown in D(iii) and assoc
(v) and captured associated stroma are shown in D(vi).Coomassie Blue staining. As shown by the graph in Fig. 2B, shorter
separation resulted in no signiﬁcant increase in the number of
proteins identiﬁed from 2 mg as to 4 mg. Furthermore, loading
greater than 2 mg runs the risk of causing blockages in the column.
Therefore, it is preferable, and indeed feasible, to aim to obtain
good protein identiﬁcations with only 2 mg total protein. In order
to demonstrate the feasibility of the approach LCM analysis of
discrete regions within prostate tissue was conducted. For LCM
12 tissue sections from a single patient specimen were used in
order to harvest benign epithelium, its associated stroma and
tumor epithelium and its associated stroma using our systematic
workﬂow. Each step upstream and downstream of the LCM
procedure, from tissue preservation to the planning of LCM
sessions, is crucial to ensure accurate cell population accrual. Using
digital annotation software with a rigorous annotation system
allows for pre-planned LCM sessions as well as real-time viewing
of annotated images ensuring that the correct cells (and regions)
are acquired for downstream analysis. For this reason the
“telepathology” approach was chosen; whereby top, middle and
tail sections were brought forward for pathological review as
shown in Fig. 1, thus ensuring documentation of changes in tissue
morphology as the tissue was sectioned through, and also allowing
digital pathological annotation through Spectrum software. Online
viewing of annotated slides allows planning of LCM sessions as
well as real time viewing of annotated images while performing
LCM.
The overall aim of this work was to assess the optimsed LCM-
proteomics workﬂow for the proteomic proﬁling of laser captured
microdissected material. To achieve this, three technical replicates
and four sample replicates were proﬁled using label-free nLC–MS/s a schematic illustration of the optimized workﬂow from sample selection and
roﬁling using short range SDS-PAGE and LC–MS. Fig. 1B, C and D illustrate the
serial H&E stained sections taken from a patient sample. Panel A shows the ﬁrst H&E
ction taken at St. James’ Hospital. Panel C and D show the eleventh and sixteenth
a from one cut section. The annotated cresyl violet-stained section is shown in D(i),
iated stroma are shown in D(iv). Laser captured tumor epithelial cells are shown in D
Fig. 2. SDS-PAGE approach for sample concentration and protein identiﬁcations. Panel (A) shows polyacrylamide gel (6%) was used to separate 0.5 mg–15 mg of crude prostate
lysate. Panel (B) represents bar chart of total protein digested as compared to number of proteins identiﬁed using LC–MS.
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by the densitometry of the Coomassie-stained concentrated
protein bands prior to tryptic digestion, Technical replicates were
analysed at the start, middle and end of the label-free experiment
and sample replicates were prepared individually and analysed
throughout the experiment. The current high resolution MS
instrumentation allows accurate and in depth analysis of the
proteome, where careful experimental design as well as attention
to detail at every stage from sample preparation, protein digestion
and mass spectrometric analysis plays a role in the total number of
proteins identiﬁed reproducibly and accurately during label-free
proteomic proﬁling. In total over 2000 proteins were identiﬁed
from LCM material (FDR <1%). Technical replicates (n = 3) showed
an average Pearson correlation of 0.99% in the proteins identiﬁed
(Fig. 3B). Moreover sample replicate (n = 4) correlation showed
strong technical reproducibility with an average Pearson correla-
tion of 0.97 (Fig. 3A). The technical and sample variance, as
measured by % CV  standard deviation across three technical
replicates and four sample replicates are plotted against their
average abundance on the log 10 scale for all identiﬁed peptides
(FDR > 0.01%). Fig. 3C and 3D represents the % CV versus peptide
abundance for technical and sample replicates respectively. The
graphs show excellent reproducibility with % CV <15% clearly
demonstrating the reproducibility of the methodology. This
demonstrates the overall feasibility of proteomic proﬁling of
limited quantities of protein, routinely acquired using LCM, from
multiple patient samples. In conclusion, the rigorous approach
described here which includes a telepathology approach as well as
standardized protocols for protein digestion, MS experimentaldesign and data acquisition provides a platform for reproducible
protein identiﬁcation and quantiﬁcation of laser captured micro-
dissected material.
2. Materials and methods
2.1. Tissue samples
Tissue specimens were collected from patients who had
consented to have clinical data collected prospectively and to
provide all prostate tissue obtained during biopsy and surgery. A
single prostate tissue specimen was obtained from the Irish
Prostate Cancer Research Consortium Tissue Bank and selected
based upon pathological review. Snap frozen tissue was mounted
on a tissue holder with the assistance of Tissue-Tek O.C.T (Sakura,
SAK 4583) and fresh frozen tissue sections were cut onto individual
glass slides; a single tissue section (5 mm thick) were stained with
hematoxylin and eosin (H and E) for pathological review.
2.1.1. Protein preparation and short range SDS-PAGE
For the preparation of protein extracts, the tissue specimen was
ground, in the presence of liquid nitrogen, into a ﬁne powder using
pestle and mortar. Protein powder was suspended in 1 ML of lysis
buffer (20 mM Tris, 7 M Urea, 2 M Tiourea, 10 mg/ml DTT). In
addition, buffer was supplemented with a protease inhibitor
cocktail (0.2 mM pefabloc, 1.4 mM pepstatin, 0.15 mM aprotinin,
0.3 mM E-64, 1 mM leupetin, 0.5 mM soybean trypsin inhibitor and
1 mM EDTA) to avoid proteolytic degradation of proteins. Soluable
middle layer proteins were extracted following centrifugation at
Fig. 3. Technical and sample reproducibility of protein identiﬁcations and peptide abundance by label-free LC–MS.Pearson correlation plot of protein identiﬁcations for
sample (A) and (B) technical replicates. Variance as measured by% CV  standard deviation across four sample replicates (C) and three technical replicates (D), are plotted
against their average peptide abundance on the log 10 scale.
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placed in Lo-Bind 0.5 ml tubes (Sigma, Z666491) for subsequent
short range SDS-PAGE on 6% polyacrylamide gels [12] and
electrophoresis was performed at 80 V for 20 min or until the
tracking dye fully entered the top of the resolving gel.
2.1.2. Protein digestion and LC–MS/MS
Concentrated protein bands were excised, washed and digested
according to an optimized method [13]. Trypsin-generated
peptides were dried by vacuum centrifugation and the peptide
fractions were resuspended and prepared for LC–MS/MS analysis
using C18 Stage tips according to Rappsilber et al. [14]. Digested
samples were analysed on a Thermo Scientiﬁc Q-Exactive mass
spectrometer coupled to a Dionex Ultimate 3000 (RSLCnano)
chromatography system. Each sample was loaded onto a Biobasic
Picotip Emitter (120 mm length, 75 mm ID) column packed with
Reprocil Pur C18 (1.9 mm) reverse phase media and peptides
separated by an increasing acetonitrile gradient over 120 min at a
ﬂow rate of 250 nL/min using buffer A (97% H2O, 2.5% acetonitrile,
0.5% acetic acid) and buffer B (97% acetonitrile, 2.5% H2O, 0.5%
acetic acid). From 0–16 min the sample was loaded on to the
column at 500 nl/min, from 16 to 17 min buffer B increased from
1 to 2% and the ﬂow rate decreased from 500 to 250 nl/min, from
17 to 123 min buffer B increased from 2 to 27% at a ﬂow rate of
250 nl/min. From 123–124 min buffer B increased from 27 to 90%
and the ﬂow rate increased from 250 to 500 nl/min. From 124 to
130 min buffer B remained at 90% and a ﬂow rate of 500 nl/min.
From 130 to 131 min buffer B decreased from 90 to 1% at a ﬂow rate
of 500 nl/min. From 131 to 132 min buffer B remained at 1% at a
ﬂow rate of 500 nl/min. The mass spectrometer was operated in
positive ion mode with a capillary temperature of 220 C, and with
a potential of 2300 V applied to the frit. All data was acquired withthe mass spectrometer operating in automatic data dependent
switching mode. A high resolution (70,000) MS scan (300–1600 m/
z) was performed to select the 12 most intense ions prior to MS/MS
analysis using HCD. Raw data was de novo sequenced and searched
against the Homo Sapiens subset of the Uniprot database
(2014_11 version) using the search engine PEAKS Studio 6 (version
6) with the following parameters applied: enzyme: trypsin, up to
two missed cleavages, ﬁxed modiﬁcations: carbimidomethylated
cysteine, variable modiﬁcations: oxidation methionine, precursor
ion tolerance: 10 ppm, product ion tolerance: 0.3 Da and maximum
variable post translational modiﬁcations per peptide: 3 with a false
discovery rate (FDR) of 1%, average local conﬁdence (ALC) of
65%, a total local conﬁdence of (TLC) of 6, and peptide score
(10l gP) of 15. Subsequently, the raw data ﬂies were processed
through MaxQuant (V.1.2.7.4) software with the same parameter
settings as Peaks Studio 6 and including: peptide and protein false
discover rate were set to 0.1%, unique and razor peptides were set
at 1 for protein identiﬁcations. The Label free Quantiﬁcation (LFQ)
values were generated with a minimum of 2 peptides required per
protein.
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